Izvorni znanstveni članak

https://doi.org/10.37797/ig.42.1.1

Croatian Society for Infectious Diseases recommendations for diagnosis and treatment of multisystem inflammatory syndrome in children

Laura Prtorić ; Klinika za infektivne bolesti "Dr. Fran Mihaljević", Zagreb, Hrvatska
Hrvoje Kniewald ; Klinički bolnički centar Sestre milosrdnice, Zagreb, Hrvatska
Srđan Roglić orcid.org/0000-0002-4441-2600 ; Klinika za infektivne bolesti "Dr. Fran Mihaljević", Zagreb, Hrvatska; Medicinski fakultet Sveučilišta u Zagrebu, Zagreb, Hrvatska
Lorna Stemberger Marić ; Klinika za infektivne bolesti "Dr. Fran Mihaljević", Zagreb, Hrvatska; Medicinski fakultet Sveučilišta u Zagrebu, Zagreb, Hrvatska
Goran Tešović ; Klinika za infektivne bolesti "Dr. Fran Mihaljević", Zagreb, Hrvatska; Medicinski fakultet Sveučilišta u Zagrebu, Zagreb, Hrvatska

Sažetak

Multisystem inflammatory syndrome in children is a novel entity first described in April 2020. It is a complication of COVID-19 that appears with a latency of 2-6 weeks and is characterized by fever, multiorgan involvement, and elevated inflammatory markers. Diagnosis is based on certain diagnostic criteria, and in these recommendations we chose the World Health Organization case definition. Patients should be treated with intravenous immunoglobulin and glucocorticoids together with other symptomatic and supportive measures. Follow-up should be at least a year-long, and even longer in case of cardiac complications. The aim of these recommendations is to help clinicians in diagnosing and treating this disease

Ključne riječi

multisystem inflammatory syndrome in children (MIS-C); diagnosis; treatment

Hrčak ID:

300814

URI

https://hrcak.srce.hr/300814

Datum izdavanja:

25.4.2023.

Podaci na drugim jezicima: hrvatski

Posjeta: 538 *